[HTML][HTML] Optimizing the evaluation of gene-targeted panels for tumor mutational burden estimation

Y Li, Y Luo - Scientific reports, 2021 - nature.com
Though whole exome sequencing (WES) is the gold-standard for measuring tumor
mutational burden (TMB), the development of gene-targeted panels enables cost-effective …

[HTML][HTML] Optimizing the evaluation of gene-targeted panels for tumor mutational burden estimation

Y Li, Y Luo - Scientific Reports, 2021 - ncbi.nlm.nih.gov
Though whole exome sequencing (WES) is the gold-standard for measuring tumor
mutational burden (TMB), the development of gene-targeted panels enables cost-effective …

Optimizing the evaluation of gene-targeted panels for tumor mutational burden estimation

Y Li, Y Luo - Scientific reports, 2021 - scholars.northwestern.edu
Though whole exome sequencing (WES) is the gold-standard for measuring tumor
mutational burden (TMB), the development of gene-targeted panels enables cost-effective …

Optimizing the evaluation of gene-targeted panels for tumor mutational burden estimation.

Y Li, Y Luo - Scientific Reports, 2021 - europepmc.org
Though whole exome sequencing (WES) is the gold-standard for measuring tumor
mutational burden (TMB), the development of gene-targeted panels enables cost-effective …

Optimizing the evaluation of gene-targeted panels for tumor mutational burden estimation

Y Li, Y Luo - Scientific reports, 2021 - pubmed.ncbi.nlm.nih.gov
Though whole exome sequencing (WES) is the gold-standard for measuring tumor
mutational burden (TMB), the development of gene-targeted panels enables cost-effective …

Optimizing the evaluation of gene-targeted panels for tumor mutational burden estimation.

Y Li, Y Luo - Scientific Reports, 2021 - search.ebscohost.com
Though whole exome sequencing (WES) is the gold-standard for measuring tumor
mutational burden (TMB), the development of gene-targeted panels enables cost-effective …

Optimizing the evaluation of gene-targeted panels for tumor mutational burden estimation

Y Li, Y Luo - Scientific Reports, 2021 - ui.adsabs.harvard.edu
Though whole exome sequencing (WES) is the gold-standard for measuring tumor
mutational burden (TMB), the development of gene-targeted panels enables cost-effective …